August
12
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
Company delivers $11.2M in revenues resulting in 52% growth year-over-year and 22% growth quarter-over-quarterBroadened PEDD portfolio...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.